LSX World Congress

Early confirmed speakers

The Congress speaker faculty brings you the knowledge and experience of some of the best in the business. Check back for updates. If you'd like to join them get in touch with us today!

You can also review the Biotech Leaders and Healthtech Leaders.

Medtech Leaders
Maarten Akkerman, Vice President Medical Affairs and Value-Based Healthcare, Medtronic

Maarten Akkerman

Vice President Medical Affairs and Value-Based Healthcare
Medtronic
Xavier Bertrand, VP Healthcare Services and Alliances, Boston Scientific

Xavier Bertrand

VP Healthcare Services and Alliances
Boston Scientific
Georg Bortlein, Founder & President, High Life

Georg Bortlein

Founder & President
High Life
Alain Chevallier, Senior Partner, Truffle Capital

Alain Chevallier

Senior Partner
Truffle Capital
Juliette Cook, Vice President Quality & Regulatory Affairs, Implantica

Juliette Cook

Vice President Quality & Regulatory Affairs
Implantica
Ian Crosbie, CEO, Sequana Medical

Ian Crosbie

CEO
Sequana Medical
Susana de Azevedo Wäsch, VP Quality Management & Regulatory Affairs, Ypsomed AG

Susana de Azevedo Wäsch

VP Quality Management & Regulatory Affairs
Ypsomed AG
Jonathan Goldstein, Director, Global Technology Partnerships, Boston Scientific

Jonathan Goldstein

Director, Global Technology Partnerships
Boston Scientific
Thomas Hummel, Head of Strategy & Innovation, Siemens Healthineers

Thomas Hummel

Head of Strategy & Innovation
Siemens Healthineers
Marc Julien, Co-CEO, Diabeloop

Marc Julien

Co-CEO
Diabeloop
Oliver Keown, Director, Intuitive Ventures

Oliver Keown

Director
Intuitive Ventures
Charity Kufaas, VP BD and Strategy, Medtronic

Charity Kufaas

VP BD and Strategy
Medtronic
Lucy Mackillop, Chief Medical Officer, Sensyne Health

Lucy Mackillop

Chief Medical Officer
Sensyne Health
Frank Maddux, Global Chief Medical Officer, Fresenius Medical Care

Frank Maddux

Global Chief Medical Officer
Fresenius Medical Care
Markus Ott, VP and Head of Global Market Access and Health Policy, Roche Diagnostics

Markus Ott

VP and Head of Global Market Access and Health Policy
Roche Diagnostics
Andrea Rappagliosi, VP Market Access, Public Affairs & Communications, EMEA, Canada and LATAM, Edwards Life Sciences

Andrea Rappagliosi

VP Market Access, Public Affairs & Communications, EMEA, Canada and LATAM
Edwards Life Sciences
Antonio Sanchez-Cordero, VP Business Development (M&A) Peripheral Intervention, BD

Antonio Sanchez-Cordero

VP Business Development (M&A) Peripheral Intervention
BD
Eliane Schutte, CEO, Xeltis

Eliane Schutte

CEO
Xeltis
Graeme Smith, CEO, Lightpoint Medical

Graeme Smith

CEO
Lightpoint Medical
Wilfred Van Zuilen, President EMEA, Zimmer Biomet

Wilfred Van Zuilen

President EMEA
Zimmer Biomet
Laurent Vandebrouck, CEO, Chronolife

Laurent Vandebrouck

CEO
Chronolife
Stephen Wildhirt, CEO, AdjuCor

Stephen Wildhirt

CEO
AdjuCor
Rupert Winckler, Head of EMEA Business Development, Olympus 300x

Rupert Winckler

Head of BD EMEA
Olympus
Andreas Wuepper, Director Investments, Europe, Fresenius Medical Care Ventures

Andreas Wuepper

Director Investments, Europe
Fresenius Medical Care Ventures
DOWNLOAD BROCHURE
ABOUT

LSX is an influential community of senior life science decision makers.

We connect senior biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.

 
RESOURCES

Female Founders

Femtech Leaders

Food Biotech

Inv€$tival Showcase

Lifestars Awards

Longevity Leaders

LSX Nordic Congress

LSX USA Congress

LSX World Congress

RNA Leaders

The $yndicate

Workforce Wellbeing
LINKS

Home

About

Team

Partners

Resources

FAQs

Contact


© 2020 All Rights Reserved By LSX Ltd | Privacy Policy